JP2024529960A5 - - Google Patents

Info

Publication number
JP2024529960A5
JP2024529960A5 JP2024504817A JP2024504817A JP2024529960A5 JP 2024529960 A5 JP2024529960 A5 JP 2024529960A5 JP 2024504817 A JP2024504817 A JP 2024504817A JP 2024504817 A JP2024504817 A JP 2024504817A JP 2024529960 A5 JP2024529960 A5 JP 2024529960A5
Authority
JP
Japan
Application number
JP2024504817A
Other languages
Japanese (ja)
Other versions
JP2024529960A (ja
JPWO2023009754A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/038723 external-priority patent/WO2023009754A2/en
Publication of JP2024529960A publication Critical patent/JP2024529960A/ja
Publication of JP2024529960A5 publication Critical patent/JP2024529960A5/ja
Publication of JPWO2023009754A5 publication Critical patent/JPWO2023009754A5/ja
Pending legal-status Critical Current

Links

JP2024504817A 2021-07-28 2022-07-28 タンパク質-抗ウイルス化合物コンジュゲート Pending JP2024529960A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163226713P 2021-07-28 2021-07-28
US63/226,713 2021-07-28
PCT/US2022/038723 WO2023009754A2 (en) 2021-07-28 2022-07-28 Protein-antiviral compound conjugates

Publications (3)

Publication Number Publication Date
JP2024529960A JP2024529960A (ja) 2024-08-14
JP2024529960A5 true JP2024529960A5 (https=) 2025-10-16
JPWO2023009754A5 JPWO2023009754A5 (https=) 2025-10-16

Family

ID=83115616

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024504817A Pending JP2024529960A (ja) 2021-07-28 2022-07-28 タンパク質-抗ウイルス化合物コンジュゲート

Country Status (10)

Country Link
US (1) US20250041433A1 (https=)
EP (1) EP4376895A2 (https=)
JP (1) JP2024529960A (https=)
KR (1) KR20240038928A (https=)
CN (1) CN117813119A (https=)
AU (1) AU2022320713A1 (https=)
CA (1) CA3220081A1 (https=)
IL (1) IL307947A (https=)
MX (1) MX2024000897A (https=)
WO (1) WO2023009754A2 (https=)

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4393937A (en) 1981-03-25 1983-07-19 Shell Oil Company Olefin sulfonate-improved steam foam drive
US5208020A (en) 1989-10-25 1993-05-04 Immunogen Inc. Cytotoxic agents comprising maytansinoids and their therapeutic use
US5714586A (en) 1995-06-07 1998-02-03 American Cyanamid Company Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates
US6596541B2 (en) 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US20070258987A1 (en) 2000-11-28 2007-11-08 Seattle Genetics, Inc. Recombinant Anti-Cd30 Antibodies and Uses Thereof
AR048098A1 (es) 2004-03-15 2006-03-29 Wyeth Corp Conjugados de caliqueamicina
US7750116B1 (en) 2006-02-18 2010-07-06 Seattle Genetics, Inc. Antibody drug conjugate metabolites
WO2008122039A2 (en) 2007-04-02 2008-10-09 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Selenocysteine mediated hybrid antibody molecules
JP2010528285A (ja) 2007-05-23 2010-08-19 ベンタナ・メデイカル・システムズ・インコーポレーテツド 免疫組織化学およびinsituハイブリダーゼーションのためのポリマー担体
EP2276506A4 (en) 2008-04-30 2014-05-07 Immunogen Inc EFFICIENT CONJUGATES AND HYDROPHILIC BINDER
DK2528625T3 (da) 2010-04-15 2013-10-14 Spirogen Sarl Pyrrolobenzodiazepiner og konjugater deraf
US20130244905A1 (en) 2010-07-06 2013-09-19 Ed Grabczyk Reporter for RNA Polymerase II Termination
US9676871B2 (en) 2010-11-05 2017-06-13 Pfizer Inc. Engineered polypeptide conjugates and methods for making thereof using transglutaminase
KR20140037105A (ko) 2011-05-27 2014-03-26 암브룩스, 인코포레이티드 비-천연 아미노산 연결된 돌라스타틴 유도체를 함유하는 조성물, 이를 수반하는 방법, 및 용도
US8815226B2 (en) 2011-06-10 2014-08-26 Mersana Therapeutics, Inc. Protein-polymer-drug conjugates
CA2850096C (en) 2011-10-14 2018-07-03 Spirogen Sarl Synthesis method and intermediates useful in the preparation of pyrrolobenzodiazepines
ES2945932T3 (es) 2011-10-14 2023-07-10 Seagen Inc Pirrolobenzodiazepinas y conjugados dirigidos
CA2850103C (en) 2011-10-14 2019-09-10 Spirogen Sarl Pyrrolobenzodiazepines
WO2013055993A1 (en) 2011-10-14 2013-04-18 Seattle Genetics, Inc. Pyrrolobenzodiazepines and targeted conjugates
WO2013068874A1 (en) 2011-11-11 2013-05-16 Pfizer Inc. Antibody-drug conjugates
FI2911699T4 (fi) 2012-10-23 2025-12-09 Synaffix Bv Muokattu vasta-aine, vasta-ainekonjugaatti ja menetelmä niiden valmistamiseksi
TWI702229B (zh) 2014-12-19 2020-08-21 美商再生元醫藥公司 流行性感冒病毒血球凝集素之人類抗體
CN112672762B (zh) * 2018-07-26 2025-06-13 普渡研究基金会 用于抗流感化学治疗和免疫治疗的小分子配体靶向药物缀合物
AU2021210987A1 (en) * 2020-01-24 2022-08-04 Regeneron Pharmaceuticals, Inc. Protein-antiviral compound conjugates

Similar Documents

Publication Publication Date Title
CL2026000097A1 (es) Aparato, sistema y método para monitorizar los procesos de envejecimiento y/o maceración de una bebida alcohólica en una barrica y bedida alcohólica obtenida
JP2024529960A5 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BY13170U (https=)
BY13174U (https=)
CN307049755S (https=)
CN307049114S (https=)
CN307048226S (https=)
CN307047455S (https=)
CN307045975S (https=)
CN307045942S (https=)
CN307045584S (https=)
CN307045108S (https=)
CN307044909S (https=)
CN307044483S (https=)
CN307044346S (https=)
CN307044261S (https=)
BY23963C1 (https=)
BY13176U (https=)
BY13175U (https=)
BY13172U (https=)
BY13169U (https=)
BY13168U (https=)
BY13167U (https=)